In the "Mad Mail" viewer feedback segment, Cramer followed up on Globus Medical (GMED - Get Report) a recent biotech IPO. He said this company has some headwinds and he'd rather be in Johnson & Johnson (JNJ - Get Report).Cramer was also cautious on Northern Tier Energy (NTI), a master limited partnership with a 12% yield. Cramer said this company is also intriguing, but he prefers Holly Frontier (HFC). Cramer was more upbeat on Casey's General (CASY), saying this stock can be bought and has about 10 points of upside. He was less optimistic on Sodastream (SODA), however, calling the stock "controversial." Finally, when asked how to play stocks like Limited Brands (LTD) that offer special dividends, Cramer said it's not magic, share prices just get adjusted after the dividend is paid. If you liked the stock before, he said, you should still like it after the dividend.
No Huddle OffenseIn his "No Huddle Offense" segment, Cramer opined on the bizarre moves in the tech sector. He said the markets continue to pound all things Apple including such stocks as Cirrus Logic (CRUS) and Qualcomm (QCOM). Meanwhile, stocks including Hewlett-Packard (HPQ) and Microsoft (MSFT) continue as lessons in losing money. But other areas of tech are doing well, noted Cramer, including Adobe (ADBE), Juniper Networks (JNPR) and EMC (EMC). Cramer told investors they need to stick with companies that are beating expectations and steer clear of Apple, as least until year's end. To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts